Publications for Wilbert S. Aronow wilbert_aronow@nymc.edu
Valentova, M., Morgan, C. J., Butler, J., Blackman, M. R., Fonarow, G. C., Deedwania, P., . . . Aronow, W. S. (2016). Hypokalemia and long-term outcomes in patients hospitalized for heart failure: A propensity-matched study. European Journal of Heart Failure, 18(Suppl 1), 263-264.
Vinson, L. D., Hemmy Asamsama, O., Arundel, C., Blackman, M., Aronow, W., Allman, R. M., & Ahmed, A. (2016). Are nursing home residents hospitalized for heart failure at higher risk for 30-day readmission? Gerontologist, 56(Suppl 3), 552. doi:10.1093/geront/gnw162.2222
Weerakoon, S., Tsimploulis, A., Arundel, C., Blackman, M., Morgan, C., Butler, J., . . . Aronow, W.S. (2016). Clinical effectiveness of digoxin in hospitalized older patients with heart failure and preserved ejection fraction: A propensity-matched study of medicare-linked OPTIMIZE-HF. Circulation, 134(Suppl 1), A20752. This material can be found here.
Yandrapalli, S., Aronow, W. S., Gass, A. L., Aggarwal, C., Frishman, W. H., Panza, J. A., . . . Lanier, G. M. (2016). Trends in sepsis and in-hospital mortality among heart transplant patients: A United States National Study. Circulation, 134(Suppl 1), A20503. This material can be found here.
Young, R. K., Goodlin, S., Wu, W. C., Morgan, C., Zhang, S., Bearden, D., . . . Aronow, W. S. (2016). Chronic opioid use is associated with significant higher 12-month all-cause readmission and all-cause mortality but not associated with 30-day all-cause readmission or all-cause mortality in older medicare beneficiaries hospitalized for heart failure. Journal of the American College of Cardiology, 67(13), 1428. This material can be found here.
Abdelmawgoud, A., Brown, C. J., Sui, X., Fonarow, G. C., Kokkinos, P. F., Bittner V, . . . Aronow, W. S. (2015). Relationship of physical activity and healthy eating with mortality and incident heart failure among community-dwelling older adults with normal body mass index. ESC Heart Failure, 2(1), 20-24. doi:10.1002/ehf2.12028
Ahmed, A. A., Patel, K., Nyaku, M. A., Kheirbek, R. E., Bittner, V., Mujib, M., Aronow, W. S.(2015). Risk of heart failure and death after prolonged smoking cessation: Role of amount and duration of prior smoking. Circulation. Heart Failure, 8(4), 694-701. doi:10.1161/CIRCHEARTFAILURE.114.001885
Aronow, W. S. (2015). 2015 American Heart Association/American College of Cardiology/American Society of Hypertension Guidelines on treatment of hypertension in patients with coronary artery disease. Journal of Hypertension: Open Access, 4, [Article e113]. doi:10.4172/2167-1095.1000e113
Aronow, W. S. (2015). 2015 guidelines on treatment of hypertension in patients with coronary artery disease. Journal of Cardiology and Therapy, 2(5), 418-421. This material can be found here.
Aronow, W. S. (2015). Blood pressure goals and targets in the elderly. Current Treatment Options in Cardiovascular Medicine, 17(7), 394. doi:10.1007/s11936-015-0394-x
Aronow, W. S. (2015). Blood pressure target goals from guidelines of 2002–2014. Future Cardiology, 11(3), 247-250. doi:10.2217/FCA.14.84
Aronow, W. S. (2015). Current therapy of hypercholesterolemia. Medical and Clinical Research, 1(1). This material can be found here.
Aronow, W. S. (2015). Diagnosis of cardiac homochromatosis. Heart Health Open Access, 2(2), 115. This material can be found here.
Aronow, W. S. (2015). Drug treatment of hypercholesterolemia. Heart Health Open Access, 2(1), [Article 112]. This material can be found here.
Aronow, W. S. (2015). Hypertension in patients with coronary artery disease. Heart Health Open Access, 2(1), [Article 111]. This material can be found here.
Aronow, W. S. (2015). Lessons learned from the TOPCAT trial. Journal of Clinical and Experimental Cardiology, 6, [Article e138]. doi:10.4172/2155-9880.1000e138
Aronow, W. S. (2015). Lipid-lowering therapy in older persons. Archives of Medical Science, 11(1), 43-56. doi:10.5114/aoms.2015.48148
Aronow, W. S. (2015). Management of hypertension in the elderly. Current Cardiovascular Risk Reports, 9, [Article 41]. doi:10.1007/s12170-015-0469-y
Aronow, W. S. (2015). Mesenteric vascular ischemia. Angiology Open Access, 3, [Article e112]. doi:10.4172/2329-9495.1000e112
Aronow, W. S. (2015). Multiple blood pressure medications and mortality among elderly individuals. JAMA, 313(13), 1362-1363. doi:10.1001/jama.2015.248
Aronow, W. S. (2015). Neurogenic stress cardiomyopathy associated with subarachnoid hemorrhage. Future Cardiology, 11(1), 77-87. doi:10.2217/fca.14.73
Aronow, W. S. (2015). Newer targets and therapies for hypertension and dyslipidemia in diabetic patients. Cardiovascular Endocrinology, 4(1), 11-16. doi:10.1097/XCE.0000000000000043
Aronow, W. S. (2015). Optimal systolic blood pressure goal in persons aged 60 years and older. Annals of Clinical and Experimental Hypertension, 3(2), 1023. This material can be found here.
Aronow, W. S. (2015). PCSK9 inhibitors. Cardiovascular Pharmacology Open Access, 4, [Article e128]. doi:10.4172/2329-6607.1000e128
Aronow, W. S. (2015). Regional differences in heart failure with preserved ejection fraction trials. Journal of Cardiovascular Disorders, 2(1), [Article 1008]. doi:10.1161/CIRCULATIONAHA.114.013637
